MDxHealth SA revised earnings guidance for the year 2024. For the period, the company is increasing 2024 revenue guidance to $83 million to 85 million from the previous $79 million to 81 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 USD | +0.73% | +0.73% | -30.20% |
May. 01 | MDxHealth SA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 01 | Transcript : MDxHealth SA, Q1 2024 Earnings Call, May 01, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.20% | 75.04M | |
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- MDXH Stock
- News MDxHealth SA
- MDxHealth SA Revises Earnings Guidance for the Year 2024